Results 321 to 330 of about 17,091,208 (373)
Some of the next articles are maybe not open access.

Retrospective evaluation of shortened prothrombin time or activated partial thromboplastin time for the diagnosis of hypercoagulability in dogs: 25 cases (2006-2011).

Journal of Veterinary Emergency and Critical Care, 2016
OBJECTIVE To evaluate the relationship between shortened prothrombin time (PT) or activated partial thromboplastin time (aPTT) values, clinical findings associated with hypercoagulability, suspicion of pulmonary thromboembolism (PTE), D-dimer ...
Jennifer Song   +2 more
semanticscholar   +1 more source

Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.

International journal of clinical pharmacology and therapeutics, 2014
OBJECTIVES To assess the impact of sugammadex on activated partial thromboplastin time (APTT) and international normalized ratio for prothrombin time (PT(INR)) in healthy subjects and characterize the concentration-dependency of sugammadex effects on ...
P. De Kam   +7 more
semanticscholar   +1 more source

Consumption Time Is Not Prothrombin Time

JAMA, 1964
To the Editor:— Regarding the communication, "Spontaneous Intracranial Hematomas in Patients Receiving Anticoagulation Therapy" (JAMA187:396 [Feb 8] 1964), Drs. Dooley and Perlmutter comment that "The degree of anticoagulation in patients receiving coumarin derivatives is usually evaluated by measuring the prothrombin consumption time." It is ...
  +7 more sources

A fully integrated prothrombin time test on the microfluidic disk analyzer.

Journal of Nanoscience and Nanotechnology, 2013
A fully integrated prothrombin time test, which is capable of measuring the time required for blood to coagulate, is presented in this study. The microfluidic functions integrated on the microfluidic disk were able to extract the plasma from whole blood ...
Chia-Hui Lin   +2 more
semanticscholar   +1 more source

The Influence of Heparin on the Prothrombin Time

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1991
We studied the effect of known concentrations of heparin on the prothrombin time (PT) in patients receiving warfarin and in controls who were not anticoagulated. Plasma from the subjects and controls was serially diluted with known concentrations of heparin, and PT was measured.
Terrill K. Rosborough   +2 more
openaire   +2 more sources

Thromboplastin Time (Prothrombin Time)

1965
Publisher Summary This chapter elaborates thromboplastin time that is, prothrombin time. Blood plasma contains 300–400 mg% fibrinogen, and during coagulation of blood this is converted to insoluble fibrin by thrombin. The highly active enzyme thrombin is formed from an inactive precursor, prothrombin.
openaire   +2 more sources

Prothrombin-Time Methods

JAMA: The Journal of the American Medical Association, 1965
To the Editor:— Oral anticoagulation remains a complicated subject involving many facets, but one variable could be made a constant if the one-stage prothrombin time were carried out by the standard technique outlined over 25 years ago, when I explicitly described the preparation of thromboplastin.
Armand J. Quick, Herbert S. Sise
openaire   +2 more sources

Simplified Prothrombin Time Standardization

Pathophysiology of Haemostasis and Thrombosis, 1994
An analysis of prothrombin time (PT) standardization methods is presented. The present recommended ratio method demonstrated complex calibration and wide therapeutic ranges. Standardization by coagulation activities resulted in different therapeutic ranges due to the different sensitivity of assays for the protein induced by vitamin K absence (Pivka ...
Ingebrigt Talstad, Knut Korsbrekke
openaire   +3 more sources

The prothrombin time test [PDF]

open access: possible, 1992
The prothrombin time (PT) is the screening test for the extrinsic (tissue) clotting system. The PT was originally introduced by Quick1 as a measure of a coagulation defect in the newborn and jaundiced patients, and subsequently adapted for its present principal uses in the screening of extrinsic clotting and in monitoring of oral anticoagulant dosage ...
openaire   +1 more source

The action of Dicumarol in the human being on plasma prothrombin time and total prothrombin time

American Heart Journal, 1952
Abstract In man, Dicumarol causes an increase in the plasma and in the total prothrombin times. The explanation is offered that Dicumarol reduces both the free and total prothrombin and that a rough ratio between the two forms is maintained. The practical significance of this observation is discussed.
Clara V. Hussey   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy